Nov 14, 2025 | General Interest
Shared from healthcentral.com It’s been more than half a century since the last major innovation in Parkinson’s disease (PD) treatment. But now, a new medication is showing the potential to be another breakthrough. After successful phase 3 clinical trials on...
Nov 14, 2025 | General Interest
Shared from parkinsonsnewstoday.com. A $1.9 million U.S. Department of Defense–funded Phase 2 clinical trial will test SwallowFIT, a targeted exercise program designed to retrain the brain’s ability to control the muscles involved in swallowing — a function often...
Nov 14, 2025 | General Interest
Shared from lsvtglobal.com. In this episode, we explore the innovative “Coach Approach” to Parkinson’s voice therapy with Leanne Smith, one of the speech clinicians behind the successful technology-supported LSVT LOUD® program with NHS Scotland. Facing...
Nov 7, 2025 | General Interest
Shared from parkinsonsnewstoday.com. Irlab Therapeutics has announced new advancements for its three symptoms-targeting Parkinson’s disease drugs — medications designed to treat apathy, prevent falls, and reduce uncontrolled movements, known as dyskinesia, among...
Oct 31, 2025 | General Interest
Shared from myparkinsonsteam.com. Parkinsonism is a syndrome, or collection of symptoms, characterized by motor issues — bradykinesia (slowed movements), tremors, loss of balance, and stiffness. There are many types of parkinsonism, which are classified by their...
Oct 24, 2025 | General Interest
Shared from lsvtglobal.com. Purpose doesn’t disappear with a diagnosis – it evolves. In honor of Lewy Body Dementia Awareness Month, this empowering webinar explores how individuals living with Lewy body dementia, Parkinson’s disease, and related neurological...
